ATM and cancer: Several studies demonstrated that DNA damage promotes chemoresistance and drives epithelial-to-mesenchymal transition (EMT) via the activation of altered ataxia telangiectasia mutated (ATM) dependent signaling in several cancer settings, including NSCLC [7,8].